The determinants of COVID-19 morbidity and mortality across countries
- PMID: 35393471
- PMCID: PMC8989117
- DOI: 10.1038/s41598-022-09783-9
The determinants of COVID-19 morbidity and mortality across countries
Abstract
We identify 21 predetermined country-level factors that explain marked variations in weekly COVID-19 morbidity and mortality across 91 countries between January and the end of 2020. Besides factors commonly associated with infectious diseases (e.g., population and tourism activities), we discover a list of country characteristics that shape COVID-19 outcomes. Among demographic-geographic factors, the male-to-female ratio, population density, and urbanization aggravate the severity of COVID-19, while education, temperature, and religious diversity mitigate the impact of the pandemic on morbidity and mortality. For the political-legal dimension, democracy and political corruption are aggravating factors. In contrast, female leadership, the strength of legal systems, and public trust in government significantly reduce infections and deaths. In terms of socio-economic aspects, GDP per capita, income inequality, and happiness (i.e., life satisfaction) lead to worse COVID-19 outcomes. Interestingly, technology advancement increases morbidity but reduces mortality. For healthcare factors, SARS (severe acute respiratory syndrome) experience and healthcare infrastructure help countries perform better in combating the pandemic.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.Lancet. 2022 Apr 16;399(10334):1489-1512. doi: 10.1016/S0140-6736(22)00172-6. Epub 2022 Feb 1. Lancet. 2022. PMID: 35120592 Free PMC article.
-
Diverging levels of COVID-19 governmental response satisfaction across middle eastern Arab countries: a multinational study.BMC Public Health. 2022 May 5;22(1):893. doi: 10.1186/s12889-022-13292-9. BMC Public Health. 2022. PMID: 35513805 Free PMC article.
-
Country-level determinants of the severity of the first global wave of the COVID-19 pandemic: an ecological study.BMJ Open. 2021 Feb 3;11(2):e042034. doi: 10.1136/bmjopen-2020-042034. BMJ Open. 2021. PMID: 33536319 Free PMC article.
-
Battling COVID-19 pandemic waves in six South-East Asian countries: A real-time consensus review.Med J Malaysia. 2020 Nov;75(6):613-625. Med J Malaysia. 2020. PMID: 33219168 Review.
-
The Need for the Right Socio-Economic and Cultural Fit in the COVID-19 Response in Sub-Saharan Africa: Examining Demographic, Economic Political, Health, and Socio-Cultural Differentials in COVID-19 Morbidity and Mortality.Int J Environ Res Public Health. 2020 May 15;17(10):3445. doi: 10.3390/ijerph17103445. Int J Environ Res Public Health. 2020. PMID: 32429123 Free PMC article. Review.
Cited by
-
Global landscape of COVID-19 research: a visualization analysis of randomized clinical trials.Clin Exp Med. 2024 Jan 22;24(1):14. doi: 10.1007/s10238-023-01254-3. Clin Exp Med. 2024. PMID: 38252392 Free PMC article.
-
Social equity perception and public mental health: a Chinese study with panel data.BMC Psychol. 2023 Sep 5;11(1):263. doi: 10.1186/s40359-023-01296-y. BMC Psychol. 2023. PMID: 37667305 Free PMC article.
-
Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.J Pers Med. 2024 Mar 2;14(3):281. doi: 10.3390/jpm14030281. J Pers Med. 2024. PMID: 38541023 Free PMC article. Review.
-
Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department.Endocr Metab Immune Disord Drug Targets. 2024;24(10):1224-1236. doi: 10.2174/0118715303288042240111070057. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38243977 Free PMC article.
-
Effectiveness of BBV152 vaccine and ChAdOx1-S vaccine in preventing severe disease among vaccinated patients admitted to a designated COVID-19 hospital in India.Clin Exp Vaccine Res. 2024 Jan;13(1):28-34. doi: 10.7774/cevr.2024.13.1.28. Epub 2024 Jan 31. Clin Exp Vaccine Res. 2024. PMID: 38362372 Free PMC article.
References
-
- Fama EF, MacBeth JD. Risk, return, and equilibrium: Empirical tests. J. Polit. Econ. 1973;81(3):607–636. doi: 10.1086/260061. - DOI
-
- Nace, T. Population adjusted coronavirus cases: Top 10 countries compared. Forbes (2021). https://www.forbes.com/sites/trevornace/2020/03/22/population-adjusted-c... (Accessed 22 March 2021).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous